Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Preparation method of glycopeptide hydrogel containing glucosamine unit and application of glycopeptide hydrogel to preparing postoperation scar inhibitor

A glucosamine and hydrogel technology, applied in the field of biomedicine, can solve the problems of increased cost and difficulty in artificial synthesis of decorin, and achieve the effect of saving cost and simplifying the treatment process

Active Publication Date: 2012-07-25
WUHAN UNIV
View PDF2 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the artificial synthesis of decorin is very difficult, and most of the methods currently used are aqueous injection methods, resulting in increased costs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of glycopeptide hydrogel containing glucosamine unit and application of glycopeptide hydrogel to preparing postoperation scar inhibitor
  • Preparation method of glycopeptide hydrogel containing glucosamine unit and application of glycopeptide hydrogel to preparing postoperation scar inhibitor
  • Preparation method of glycopeptide hydrogel containing glucosamine unit and application of glycopeptide hydrogel to preparing postoperation scar inhibitor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] (1) Preparation of tripeptide FMOC-Phe-Phe-Asp(OtBu)-OH containing hydrophobic N-fluorene-9-methoxycarbonyl

[0034] Using 2-chloro-trityl chloride resin (substitution degree of available chlorine on the resin is 1.32mmol / g) as a solid phase carrier, the short peptide FMOC-Phe-Phe-Asp (OtBu) was prepared by using a peptide solid-phase automatic synthesizer -OH. The peptide chain extends from the carbon-terminus to the nitrogen-terminus on the resin. The specific synthesis steps are as follows: Weigh 1.5g of 2-chloro-trityl chloride resin (the available chlorine content is 1.5×1.32=1.98mmol), and use 10mL of dichloromethane (CH 2 Cl 2 ) and N,N-dimethylformamide (DMF) for 3 washes, and then soak the resin with 10 mL of DMF for 30 minutes. Remove the DMF, add the DMF solution dissolved in FMOC-Asp(OtBu)-OH (3×1.98mmol) and diisopropylethylamine (DiEA, 4×1.98mmol) to the resin, shake and react at room temperature for 30 minutes . The reaction solution was removed, the...

Embodiment 2

[0049] (1) Preparation of tripeptide Nap-Phe-Phe-Asp(OtBu)-OH containing hydrophobic naphthyl acetyl group

[0050] With reference to the method of Example 1, the peptide chain was extended on the 2-chloro-trityl chloride resin. After the synthesis of the peptide chain was completed, a solution of naphthaleneacetic acid (2×1.98mmol), DiEA (3×1.98mmol), HBTU ( 2.4×1.98mmol) and HOBt (2.4×1.98mmol) in DMF were added to the resin, and the reaction was shaken at room temperature for 1.5 hours. Aspirate the DMF, respectively with 10mL DMF and CH 2 Cl 2 Wash the resin 3 times and dry the resin at room temperature. Add 20 mL of cutting agent (1:2:7 volume ratio of acetic acid, trifluoroethanol and CH 2 Cl 2 ) to cut the product from the resin and collect the filtrate and concentrate. The product was precipitated by adding a large amount of cold diethyl ether, filtered and washed several times, and dried overnight at room temperature.

[0051] (2) Synthesis of glycopeptide Nap-P...

Embodiment 3

[0057] (1) Preparation of tripeptide Py-Phe-Phe-Asp(OtBu)-OH containing hydrophobic pyrenebutyryl

[0058] Referring to the method of Example 1, extend the peptide chain on the 2-chloro-trityl chloride resin. After the synthesis of the peptide chain is completed, add pyrenebutyric acid (2×1.98mmol), DiEA (3×1.98mmol), HBTU (2.4×1.98mmol) and HOBt (2.4×1.98mmol) in DMF were added to the resin, and the reaction was shaken at room temperature for 1.5 hours. Aspirate the DMF, respectively with 10mL DMF and CH 2 Cl 2 Wash the resin 3 times and dry the resin at room temperature. Add 20 mL of cutting agent (1:2:7 volume ratio of acetic acid, trifluoroethanol and CH 2 Cl 2 ) to cut the product from the resin and collect the filtrate and concentrate. The product was precipitated by adding a large amount of cold diethyl ether, filtered and washed several times, and dried overnight at room temperature.

[0059] (2) Synthesis of glycopeptide Py-Phe-Phe-Asp-glucosamine containing glu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of bio-medicines, and relates to a preparation method of glycopeptide hydrogel containing a glucosamine unit. The glycopeptide hydrogel is formed by self-assembling the glycopeptide containing a glucosamine unit under physiological conditions. Because the glucosamine unit in the glycopeptide hydrogel has the function of inhibiting the postoperation scar from forming, the glycopeptide hydrogel is expected to be used as a gel inhibitor for inhibiting the postoperation scar from forming. The novel glycopeptide hydrogel has the two advantages that the gel is easily placed in an operation point through an injection method; and because glucosamine fixed inside the gel can not disperse in a wound region, once injection is needed during application, the treatment process is simplified and cost is saved.

Description

technical field [0001] The invention relates to a preparation method of glycopeptide hydrogel containing glucosamine units and its application in the preparation of postoperative scar inhibitors, belonging to the field of biomedicine. technical background [0002] Glaucoma is an eye disease that can lead to blindness. Its clinical symptoms are high pressure in the eye that compresses the optic disc and damages the optic nerve. At present, filtering surgery is a common method for treating glaucoma, but the scar tissue formed by excessive wound healing after surgery often leads to the failure of glaucoma filtering surgery. The main causes of postoperative scar formation are postoperative inflammatory response and subconjunctival tissue fibrosis. In clinical practice, in order to effectively inhibit postoperative inflammatory response and subconjunctival tissue fibrosis, anti-proliferative drug aqueous solution needs to be injected into the patient's eyes multiple times within...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/06A61K38/14A61P17/02
Inventor 张先正许小丁梁亮冯俊姜发纲卓仁禧
Owner WUHAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com